Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital A Vallano, G Cereza, C Pedròs, A Agustí, I Danés, C Aguilera, JM Arnau British journal of clinical pharmacology 60 (6), 653-658, 2005 | 294 | 2005 |
Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa R Orriols, J Roig, J Ferrer, G Sampol, A Rosell, A Ferrer, A Vallano Respiratory medicine 93 (7), 476-480, 1999 | 191 | 1999 |
A critical review of guidelines for low back pain treatment NP Josep M. Arnau, Antoni Vallano, Anna Lopez, Ferran European Spine Journal 15 (5), 543-553, 2006 | 185 | 2006 |
Oral antispastic drugs in nonprogressive neurologic diseases: A systematic review E Montane, A Vallano, JR Laporte Neurology 63 (8), 1357-1363, 2004 | 176 | 2004 |
Regulatory framework for advanced therapy medicinal products in Europe and United States C Iglesias-Lopez, A Agustí, M Obach, A Vallano Frontiers in pharmacology 10, 921, 2019 | 168 | 2019 |
Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission C Pedrós, B Quintana, M Rebolledo, N Porta, A Vallano, JM Arnau European Journal of Clinical Pharmacology 70 (3), 361-367, 2014 | 167 | 2014 |
Appropriateness of antibiotic prescriptions in community-acquired acute pediatric respiratory infections in Spanish emergency rooms C Ochoa, L Inglada, JM Eiros, G Solis, A Vallano, L Guerra, ... The Pediatric infectious disease journal 20 (8), 751-758, 2001 | 99* | 2001 |
Estudios de utilización de medicamentos JM Arnau, A Vallano Medicamentos y salud 2, 78-82, 2000 | 98 | 2000 |
Prevalence of pain in adults admitted to Catalonian hospitals: a cross-sectional study A Vallano, J Malouf, P Payrulet, JE Baños, ... European Journal of pain 10 (8), 721-731, 2006 | 95 | 2006 |
Assessment of antibiotic prescription in acute respiratory infections in adults C Ochoa, JM Eiros, L Inglada, A Vallano, L Guerra, ... Journal of Infection 41 (1), 73-83, 2000 | 94 | 2000 |
An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians. C Pedrós, A Vallano, G Cereza, G Mendoza-Aran, A Agustí, A Aguilera, ... Drug Safety 32 (1), 77-83, 2009 | 93 | 2009 |
Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study. A Vallano, C Aguilera, JM Arnau, B JE, Laporte JR, ... British Journal of Clinical Pharmacology 47 (6), 667-672., 1999 | 90 | 1999 |
Etiología de las infecciones del tracto urinario y sensibilidad de los uropatógenos a los antimicrobianos C Ochoa Sangrador, JM Eiros Bouza, C Pérez Mendez, L Inglada Galiana, ... Revista Espanola de Quimioterapia, 2005, vol. 18, num. 2, p. 124-135, 2005 | 85 | 2005 |
Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing. A San-José, A Agustí, X Vidal, F Formiga, A López-Soto, ... European journal of internal medicine 25 (8), 710-716, 2014 | 78 | 2014 |
Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study A Vallano, JM Arnau, GP Miralda, J Pérez-Bartolí Thrombosis Journal 2, 1-7, 2004 | 66 | 2004 |
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels A Melander, P Folino-Gallo, T Walley, Schwabe, Groop, P-H, Klaukka, ... Diabetologica 49 (9), 2024-2029, 2006 | 61 | 2006 |
Medical speciality and pattern of medicines prescription A Vallano, E Montane, JM Arnau, X Vidal, C Pallares, M Coll, JR Laporte European Journal of Clínical Pharmacology 60 (10), 725-730, 2004 | 61 | 2004 |
Assessment of antibiotic prescription in acute urinary tract infections in adults VJR Martínez MA, Inglada L, Ochoa C, SSG treatments Journal of Infection 54 (3), 235-244, 2007 | 58 | 2007 |
Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis J Gratacós, C Pontes, X Juanola, J Sanz, F Torres, C Avendaño, ... Arthritis research & therapy 21, 1-10, 2019 | 56 | 2019 |
Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos A Vallano Ferraz, A Agustí Escasany, C Pedrós Xolvi, JM Arnau de Bolós Gaceta Sanitaria 26, 277-283, 2012 | 53* | 2012 |